Drug class
Phosphonic acid antibacterial; MurA enzyme inhibitor
Mechanism of action
Inhibits UDP-N-acetylglucosamine enolpyruvyl transferase (MurA), an early enzyme in bacterial peptidoglycan synthesis, blocking cell-wall formation and producing bactericidal activity.
General use cases
- Oral fosfomycin tromethamine: treatment of uncomplicated acute cystitis in women caused by susceptible organisms such as Escherichia coli and Enterococcus faecalis
- Intravenous fosfomycin formulations, where authorised, are used for selected serious infections caused by susceptible bacteria; route-specific indications are not interchangeable
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
